Madrigal Pharmaceuticals had a revenue of 321.08M in the quarter ending Dec 31, 2025, with 11.77%. This bring the company's revenue in the last twelve months to 958.40M, Decreased 29.40%. In the fiscal year ending Dec 31, 2025, Madrigal Pharmaceuticals had annual revenue of 958.40M with 432.05% growth.